{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:49:54Z","timestamp":1792432194935,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"the Russian Federation Government Megagrant","award":["14.W03.031.0025"],"award-info":[{"award-number":["14.W03.031.0025"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejmech.2019.02.044","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T16:32:24Z","timestamp":1550248344000},"page":"301-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0200-4772","authenticated-orcid":false,"given":"Mikhail","family":"Krasavin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4389-461X","authenticated-orcid":false,"given":"Anton","family":"Shetnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8912-5816","authenticated-orcid":false,"given":"Sergey","family":"Baykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kalinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Sharoyko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6205-4069","authenticated-orcid":false,"given":"Tiziano","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Korsakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana B.","family":"Tennikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.02.044_bib1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2019.02.044_bib2","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.02.044_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4155\/fmc.11.69","article-title":"Carbonic anhydrase inhibitors and activators for novel therapeutic applications","volume":"3","author":"Supuran","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14728222.2014.991312","article-title":"The \u03b7-class carbonic anhydrases as drug targets for antimalarial agents","volume":"19","author":"Supuran","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2019.02.044_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.02.044_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/138161208783877866","article-title":"The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.02.044_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.02.044_bib8","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.bmc.2017.02.018","article-title":"Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3-and 4-(hetero)arylisoxazol-5-amine scaffolds","volume":"25","author":"Krasavin","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ejmech.2019.02.044_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14756366.2016.1178248","article-title":"Isoform-selective inhibitory profile of 2-imidazoline-substituted benzenesulfonamides against a panel of human carbonic anhydrases","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib10","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/acs.jmedchem.5b01144","article-title":"Discovery of 1,1\u2032-Biphenyl-4-sulfonamides as a new class of potent and selective carbonic anhydrase XIV inhibitors","volume":"58","author":"La Regina","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib11","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/j.bmc.2017.04.007","article-title":"N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII","volume":"25","author":"Ivanova","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and Carbonic Anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/molecules23051045","article-title":"Cancer drug development of carbonic anhydrase inhibitors beyond the active site","volume":"23","author":"Singh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.02.044_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1871520616666161031143301","article-title":"The Warburg effect and the hallmarks of cancer","volume":"17","author":"Schwartz","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"48","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2019.02.044_bib16","doi-asserted-by":"crossref","first-page":"E2420","DOI":"10.3390\/ijms18112420","article-title":"Molecular-targeted therapies for epidermal growth factor receptor and its resistance mechanisms","volume":"18","author":"Yamaoka","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.02.044_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008-2018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2019.02.044_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib19","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/pro.5560071201","article-title":"Structural analysis of inhibitor binding to human carbonic anhydrase II","volume":"7","author":"Boriack-Sjodin","year":"1998","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2019.02.044_bib20","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acsmedchemlett.7b00300","article-title":"Lucky switcheroo: dramatic potency and selectivity improvement of imidazoline inhibitors of human carbonic anhydrase VII","volume":"8","author":"Kalinin","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.02.044_bib21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.06.022","article-title":"Probing the \u2018bipolar nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms","volume":"101","author":"Krasavin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/14756366.2017.1344236","article-title":"Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases","volume":"32","author":"Krasavin","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bioorg.2017.10.005","article-title":"Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms","volume":"76","author":"Krasavin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bmcl.2015.12.016","article-title":"Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors","volume":"26","author":"Yaseen","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.02.044_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-1993-25861","article-title":"One-pot preparation of 6-substituted 3(2H)-Pyridazinones from ketones","author":"Coates","year":"1993","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2019.02.044_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/14756366.2011.577036","article-title":"Synthesis and biological evaluation of some novel sulfamoylphenyl-pyridazinone as anti-inflammatory agents (Part-II)","volume":"27","author":"Bashir","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/jm00349a009","article-title":"Synthesis of pyridazine analogs of the naturally occurring nucleosides cytidine, uridine, deoxycytidine and deoxyuridine","volume":"25","author":"Katz","year":"1982","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib28","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1021\/jm701443n","article-title":"Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers","volume":"51","author":"Purohit","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib29","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bmcl.2011.01.058","article-title":"The synthesis and structure\u2013activity relationship of pyridazinones as glucan synthase inhibitors","volume":"21","author":"Ting","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.02.044_bib30","doi-asserted-by":"crossref","first-page":"43047","DOI":"10.1038\/srep43047","article-title":"Intracellular drug bioavailability: a new predictor of system dependent drug disposition","volume":"7","author":"Mateus","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.02.044_bib31","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejmech.2019.02.044_bib33","doi-asserted-by":"crossref","first-page":"21648","DOI":"10.1038\/srep21648","article-title":"PaCa-2 and PANC-1 \u2013 pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors","volume":"6","author":"Rui","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.02.044_bib34","first-page":"197","article-title":"Cobalt chloride, a chemical inducer of hypoxia-inducible factor-1a in U251 human glioblastoma cell line","volume":"14","author":"Al Okail","year":"2010","journal-title":"J.\u00a0Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.02.044_bib35","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3892\/ijo.2017.4160","article-title":"Effects of ursolic and oleanolic on SK-MEL-2 melanoma cells: in\u00a0vitro and in\u00a0vivo assays","volume":"51","author":"Caunii","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2019.02.044_bib36","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","article-title":"Dithiocarbamates strongly inhibit the \u03b2-class carbonic anhydrases from Mycobacterium tuberculosis","volume":"28","author":"Maresca","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/14756366.2011.621122","article-title":"Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds","volume":"27","author":"Ekinci","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14756366.2011.643303","article-title":"Carbonic anhydrase inhibitors: in\u00a0vitro inhibition of \u03b1 isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids","volume":"28","author":"Ekinci","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/14756366.2012.658788","article-title":"Secondary\/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II","volume":"28","author":"Alp","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.reactfunctpolym.2016.01.018","article-title":"Self-assembled spin-labeled nanoparticles based on poly(amino acids)","volume":"100","author":"Hubina","year":"2016","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.ejmech.2019.02.044_bib42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1107\/S0907444902003451","article-title":"The protein data bank","volume":"58","author":"Berman","year":"2002","journal-title":"Acta Crystallogr. D: Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.02.044_bib43","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib44","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1021\/ci500209e","article-title":"AutoDock4(Zn): an improved AutoDock force field for small-molecule docking to zinc metalloproteins","volume":"54","author":"Santos-Martins","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.02.044_bib45","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3109\/14756366.2015.1079184","article-title":"Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach","volume":"31","author":"Poli","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib46","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1021\/acs.jnatprod.6b00484","article-title":"\u03b1-Glucosidase and \u03b1-amylase inhibitors from arcytophyllum thymifolium","volume":"79","author":"Milella","year":"2016","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.02.044_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2016.02.032","article-title":"Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists","volume":"113","author":"Aghazadeh Tabrizi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.044_bib48","unstructured":"D.A. Case, J.T. Berryman, R.M. Betz, D.S. Cerutti, Darden, R.E. Duke, T.J. Giese, H. Gohlke, A.W. Goetz, N. Homeyer, S. Izadi, P. Janowski, J. Kaus, A. Kovalenko, T.S. Lee, S. LeGrand, P. Li, T. Luchko, R. Luo, B. Madej, K.M. Merz, G. Monard, P. Needham, H. Nguyen, H.T. Nguyen, I. Omelyan, A. Onufriev, D.R. Roe, A. Roitberg, R. Salomon-Ferrer, C.L. Simmerling, W. Smith, J. Swails, R.C. Walker, J. Wang, R.M. Wolf, X. Wu, D.M. York, P.A. Kollman, AMBER, Version 16, University of California, San Francisco, CA."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419301588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419301588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:46:10Z","timestamp":1694627170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419301588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":48,"alternative-id":["S0223523419301588"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.044","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}